Clariant, CH0012142631

Clariant stock climbs after Jefferies upgrades the shares

Published on 08/22/2026 at 13:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Clariant stock gained after Jefferies upgraded the shares on August 6, 2026, while the Swiss quote sat at CHF 10.43 on August 12, 2026 and market cap estimates pointed to CHF 3.3 billion.

Clariant AG (CH0012142631) - Flatlay
Clariant AG (CH0012142631) als Flatlay-Komposition mit Aktienzertifikat, ISIN-Karte und branchentypischen Objekten von oben fotografiert, Illustration mit AI erstellt.

Clariant AG (CH0012142631) climbed to CHF 10.43 on August 12, 2026, after a Jefferies upgrade on August 6, 2026 put the Swiss specialty-chemicals name back on traders' screens. The shares were up 3.88% that day, with a 5-day gain of 8.08% and a year-to-date rise of 45.67%.

What moved the shares

The catalyst was the upgrade itself, while the market backdrop stayed firm enough to keep the move visible in the quote. Clariant also traded with a 1-day range of CHF 10.43 after a session volume of 1,459,253 shares, which signals active participation rather than a quiet drift.

The stock's 52-week band ran from CHF 6.55 to CHF 10.56, so the August 12 close sat close to the upper end of the range. That matters for investors because the next leg now depends less on rerating and more on whether the business numbers justify the move.

What the latest numbers say

Clariant's latest reported half-year period was the six months ended June 30, 2026, with net sales of CHF 1.859 billion and EBITDA of CHF 331.3 million. Net income for that same period was CHF 70.3 million, versus CHF 101.5 million in the first half of 2022 and CHF 26 million in the first half of 2025, which shows how much the earnings line has moved over time.

Consensus estimates on the same data set point to CHF 3.814 billion in net sales for fiscal 2026 and CHF 672.2 million in EBITDA, with projected net income of CHF 209.3 million. The same source also shows 2026 net debt at CHF 1.226 billion, down from CHF 1.413 billion for 2025, a useful comparison as the share price sits near the top of its yearly band.

Business lines

Clariant's portfolio is still anchored by Care Chemicals, Catalysis and Natural Resources, with the business described as a Swiss specialty-chemicals producer. Catalysis remains the most product-linked part of the group, including solutions for catalysts and biofuels, while Care Chemicals and Natural Resources cover personal care, home care and industrial applications.

For investors, the key point is that the share move is being tested against a 2026 estimate set that already assumes CHF 3.814 billion of revenue, CHF 672.2 million of EBITDA and CHF 1.226 billion of net debt. That is a more demanding backdrop than a simple upgrade headline.

Clariant products

One representative product area is the Catalysis business, which covers catalyst solutions and biofuel-related applications. That segment gives the company direct exposure to industrial efficiency and process chemistry demand.

Clariant stock today

Clariant shares last traded at CHF 10.43 on August 12, 2026, with the stock up 45.67% for the year and trading within CHF 6.55 to CHF 10.56 over the past 12 months. Market value was listed at about CHF 3.3 billion on the same data set.

More on Clariant AG

Company: Clariant AG
ISIN: CH0012142631
Ticker: CLN
Exchange: Swiss Exchange
Sector / Industry: Chemie - spezialisiert
Index membership: Swiss Exchange listed name

Disclaimer...

en | CH0012142631 | CLARIANT | boerse | 69986008 | bgmi